# BPC-157: Who Should Not Take It **By TelosRX Editorial Team** · 2026-09-20 **BPC-157 is not right for everyone, and a careful intake exists specifically to identify who should not take it. This is a case for conservative judgment rather than guesswork, and your provider makes the final call. See [telosrx.com](https://telosrx.com) for general background on the peptide.** The short answer BPC-157 is not appropriate for minors, anyone who is pregnant or breastfeeding, or anyone with a health condition or medication combination a provider identifies as a concern during review. When in doubt, a conservative approach and a full medical assessment are always the right call. [Start your intake →](https://start.telosrx.com/start-online-visit/peptides) ## Who should not take BPC-157 A few categories are straightforward. BPC-157 is not appropriate for anyone under eighteen, and TelosRX does not provide it to minors under any circumstances. It is also not appropriate for anyone who is pregnant or breastfeeding. There is no adequate safety data to support use in pregnancy or lactation, and a conservative approach here means avoiding it rather than assuming it is fine. Beyond these clear categories, whether BPC-157 is appropriate depends on your individual health picture, which is exactly what a provider reviews during your [BPC-157](https://www.telosrx.com/pages/bpc-157) intake. ## Existing health conditions worth flagging Certain existing health conditions may make BPC-157 inappropriate for a specific person, even though the same condition might not rule it out for someone else. This is not a topic where a general article can give you a specific answer. What matters is being thorough and honest about your health history during intake, including conditions that feel unrelated or minor. A provider needs the full picture to make a conservative, safe decision. If you have a known condition affecting how your body processes medication generally, mention it clearly through [your intake](https://start.telosrx.com/start-online-visit/peptides) rather than assuming it does not apply to a peptide. **Key takeaway:** BPC-157 is not appropriate for minors, pregnant or breastfeeding individuals, or anyone whose provider identifies a specific concern during review. A conservative approach and full disclosure during intake protect you far better than guessing. ## Current medications and supplements Any medication or supplement you are currently taking is relevant information for your provider, even ones that seem unrelated to BPC-157's proposed uses. Because BPC-157 has a thinner published evidence base than more established medications, there is less large-scale data on interactions than there would be for a widely studied drug. That makes full disclosure during intake more important, not less. A provider reviewing a complete medication list can make a more conservative, informed decision than one working from partial information you decided to leave out. ## A history of cancer or active malignancy A history of cancer, or a currently active malignancy, deserves a careful, individualized conversation with a provider. A general article cannot give you a specific answer here. This is not a topic to guess about or self-assess. If this applies to you or has applied to you in the past, raise it directly during intake so your provider can make an appropriately conservative assessment specific to your situation. For general background on BPC-157 as studied in early research, see the [NIH PMC review on BPC 157 and the central nervous system](https://pmc.ncbi.nlm.nih.gov/articles/PMC8504390/). For how compounded medication is regulated, see the [FDA overview of compounded drug risks](https://www.fda.gov/drugs/human-drug-compounding/understanding-risks-compounded-drugs). ## Allergies and known sensitivities A known allergy or sensitivity to compounded peptides generally, or to specific ingredients used in preparation, is essential information for your provider and your compounding pharmacy. Mention any prior reaction, even a mild one, during your [BPC-157](https://www.telosrx.com/pages/bpc-157) intake. This kind of detail is exactly what a conservative review process is designed to catch. ## Why a decline is not a failure If your provider decides BPC-157 is not appropriate for you, that is the review process working correctly, not a disappointing outcome to push back against. You pay nothing if your provider declines your intake, which is meant to remove any financial pressure to withhold information in hopes of a different outcome. A decline today does not necessarily mean forever. If your health situation changes, you can revisit intake, and a provider will reassess based on your current circumstances at that time. ## When to seek medical assessment instead If you have a significant, active health concern, the right first step is a full medical assessment. A provider evaluating your overall situation matters more than a decision about a single peptide in isolation. - Any active, serious, or unstable health condition. - Pregnancy or breastfeeding. - A significant, unexplained new symptom you have not yet had evaluated. - Uncertainty about how a current medication might interact with anything new. - Any situation where you are simply unsure and want a conservative answer. None of these are reasons to feel discouraged. They are reasons to be thorough, and a thorough intake through [TelosRX](https://start.telosrx.com/start-online-visit/peptides) is built to handle exactly this kind of nuance. ## What a conservative approach looks like in practice A conservative approach means erring on the side of caution whenever there is real uncertainty. It means never assuming something is fine simply because no one has said otherwise. This applies to your provider's decisions and to your own disclosures during intake equally. When in doubt, mention it, and let a licensed professional weigh in rather than deciding on your own. This is the approach TelosRX takes seriously throughout the [BPC-157](https://www.telosrx.com/pages/bpc-157) intake process, and it is the approach that actually protects your health. ## Autoimmune conditions and immune-related concerns If you have an autoimmune condition or another immune-related concern, this is another area where individualized provider review matters more than a general statement in an article. Early research on BPC-157 has looked at various proposed mechanisms, but there is not enough published data specific to autoimmune populations to make a blanket statement either way. This uncertainty itself is a reason for a careful, conservative review. Disclose any autoimmune diagnosis clearly during your [BPC-157](https://www.telosrx.com/pages/bpc-157) intake, along with any medications you take to manage it, so your provider has full context. ## Kidney or liver conditions Conditions affecting how your body processes and clears substances generally, such as significant kidney or liver concerns, are relevant to disclose during intake. This is not because there is specific published data showing a problem with BPC-157 in these populations. It is because the overall evidence base is thin, and a conservative provider will want full information before making a decision either way. If you have a diagnosed kidney or liver condition, mention it plainly rather than deciding for yourself that it is probably not relevant. ## Recent surgery or acute injury If you have had recent surgery or an acute injury, timing and context matter for how a provider thinks about BPC-157 alongside your recovery process. This is not a category where a general article should attempt to give you a specific answer. A provider familiar with your surgical or injury history is far better positioned to weigh in than a broad statement here could be. Mention the timing and nature of any recent surgery or injury during your [intake](https://start.telosrx.com/start-online-visit/peptides) so your provider has the context needed for a conservative decision. ## When you are simply not sure Uncertainty itself is worth disclosing. If you are not sure whether something in your history is relevant, mention it anyway and let your provider decide. This applies to symptoms you have not yet had formally diagnosed, medications you take irregularly, or health concerns you have been putting off addressing. None of these are too small or embarrassing to bring up. A provider working with incomplete information cannot make a genuinely conservative decision. Completeness, not confidence, is what actually protects you here, and there is no downside to sharing more detail than you think is strictly necessary. ## If you are combining BPC-157 with another treatment Some people are interested in combining BPC-157 with another peptide or treatment they are already using, whether through TelosRX or elsewhere. This is exactly the kind of situation where full disclosure matters most. Your provider needs to know about every current treatment, not just BPC-157, to make a conservative and accurate decision. If you are already working with TelosRX on another plan, mention it clearly when you start your [BPC-157](https://www.telosrx.com/pages/bpc-157) intake so your provider has the complete picture rather than a partial one. ## Why TelosRX takes this seriously Because BPC-157 has a thinner published evidence base than more established medications, a cautious approach to who receives it matters more, not less. This is reflected in how intake is structured. Provider review exists specifically to catch situations where the peptide would not be appropriate, and that review is taken seriously rather than treated as a formality to get past. A service that approved everyone regardless of health history would not be practicing responsible medicine. The structure behind [TelosRX](https://www.telosrx.com/pages/bpc-157) intake is built to avoid exactly that outcome. This same care extends to how quarterly labs and ongoing check-ins are handled after approval. A conservative approach does not stop once you are approved. It continues throughout your entire plan, from your first intake through every future check-in. If anything changes in your health picture after you start, that same standard of full disclosure applies. Mention new medications, new diagnoses, or new symptoms as they come up, not only at your next scheduled check-in. Your care team would rather hear from you too early than too late. [Start a thorough, honest intake →](https://start.telosrx.com/start-online-visit/peptides) ## Frequently Asked Questions ### Is BPC-157 safe for pregnant or breastfeeding individuals? No. BPC-157 is not appropriate for anyone who is pregnant or breastfeeding, since there is no adequate safety data to support use in those situations. ### Can minors take BPC-157? No. BPC-157 is intended for adults only, and TelosRX does not provide it to anyone under eighteen. ### What if I have a history of cancer? This deserves a careful, individualized conversation with a provider during intake rather than a general answer. Raise it directly so your provider can make a conservative assessment. ### What should I do if I am unsure whether BPC-157 is right for me? Complete intake and disclose your full health history honestly. A licensed provider through [TelosRX](https://start.telosrx.com/start-online-visit/peptides) will make a conservative, individualized decision. ### Does declining to approve BPC-157 for me cost anything? No. If a licensed provider declines your intake, you pay nothing for that review. ### Can I try again later if I am declined? Yes, in many cases. A decline today does not necessarily mean forever. If your health situation changes, you can revisit intake and be reassessed. _TelosRX is LegitScript-certified. Compounded medication is not FDA-approved and is prepared by partner compounding pharmacies under federal regulations. This article is general information, not medical advice, and does not replace guidance from your own provider. Approval is subject to medical approval by a licensed provider, and approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service._ Questions about your plan? [Message the TelosRX care team](https://start.telosrx.com/start-online-visit/peptides) or start your evaluation at [TelosRX](https://telosrx.com). --- > Source: [Telos RX](https://www.telosrx.com/blogs/glp1/bpc-157-who-should-not-take-it)